For instance, UBE2C is commonly upregulated in intestinal-type gastric cancer, ovarian cancer, head and neck squamous cell carcinoma, pancreatic ductal adenocarcinoma, HCC, and non-small cell lung cancer [68,69,70,71,72,73,74]. This evidence concerns the gene UBE2C and ovarian carcinoma.